News

Net profit of Aarey Drugs & Pharmaceuticals rose 231.91% to Rs 1.56 crore in the quarter ended March 2026 as against Rs 0.47 crore during the previous quarter ended March 2025. Sales rose 75.27% to Rs 189.47 crore in the quarter ended March 2026 as against Rs 108.10 crore during the previous quarter ended March 2025.For the full year,net profit declined 1.24% to Rs 3.97 crore in the year ended March 2026 as against Rs 4.02 crore during the previous year ended March 2025. Sales declined 0.35% to Rs 472.27 crore in the year ended March 2026 as against Rs 473.94 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales189.47108.10 75 472.27473.94 0 OPM %2.29-3.89 -1.520.61 - PBDT2.132.04 4 8.268.04 3 PBT1.281.63 -21 5.416.10 -11 NP1.560.47 232 3.974.02 -1 Powered by Capital Market - Live News

Aarey Drugs & Pharmaceuticals has postponed the meeting of the Board of Directors which was scheduled to be held on 29 May 2026. The meeting will now be held on 30 May 2026.

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of Aarey Drugs & Pharmaceuticals declined 20.83% to Rs 0.57 crore in the quarter ended December 2025 as against Rs 0.72 crore during the previous quarter ended December 2024. Sales declined 27.92% to Rs 96.43 crore in the quarter ended December 2025 as against Rs 133.79 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales96.43133.79 -28 OPM %-1.571.64 - PBDT1.752.30 -24 PBT0.921.40 -34 NP0.570.72 -21 Powered by Capital Market - Live News

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News